INNERVATE RADIOPHARMACEUTICALS
Live / Registered — Registered (as of 24 Mar 2026)
What this means for you
Registered since 24 Mar 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 24 Mar 2032: the §8 declaration of use).
Record
- Serial number
- 99064464
- Registration number
- 8183382
- Mark type
- Word mark
- Filed
- 03 Mar 2025
- Published for opposition
- 03 Feb 2026
- Registered
- 24 Mar 2026
- Next maintenance filing
- §8 declaration of use, due by 24 Mar 2032 (grace period to 24 Sept 2032)
- Attorney of record
- Daniel P. Mullarkey
Goods and services
- Class 042 — Scientific and technological services: Scientific research; Scientific research in the field of pharmacy; Research on the subject of pharmaceuticals; Medical research; Research and development services of new pharmaceutical products; Providing scientific information in the field of biochemistry, biotechnology and clinical trials; Scientific research consulting in the field of biotechnology, pharmaceutical research and development, and genetic science in relation to radiopharmaceuticals and cancer
Owner
- INNERVATE RADIOPHARMACEUTICALS LLC, Englewood, NJ, US
- INNERVATE RADIOPHARMACEUTICALS LLC, Englewood, NJ, US
- INNERVATE RADIOPHARMACEUTICALS LLC, Englewood, NJ, US
Prosecution history
- 24 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 03 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Feb 2026 — PUBLISHED FOR OPPOSITION
- 28 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 03 Nov 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 03 Nov 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 05 Aug 2025 — NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
- 05 Aug 2025 — EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
- 05 Aug 2025 — COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
- 05 Aug 2025 — EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED